These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 24358134)

  • 1. Ras and Rac1, frequently mutated in melanomas, are activated by superoxide anion, modulate Dnmt1 level and are causally related to melanocyte malignant transformation.
    Molognoni F; de Melo FH; da Silva CT; Jasiulionis MG
    PLoS One; 2013; 8(12):e81937. PubMed ID: 24358134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress modulates DNA methylation during melanocyte anchorage blockade associated with malignant transformation.
    Campos AC; Molognoni F; Melo FH; Galdieri LC; Carneiro CR; D'Almeida V; Correa M; Jasiulionis MG
    Neoplasia; 2007 Dec; 9(12):1111-21. PubMed ID: 18084618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Timp1 interacts with beta-1 integrin and CD63 along melanoma genesis and confers anoikis resistance by activating PI3-K signaling pathway independently of Akt phosphorylation.
    Toricelli M; Melo FH; Peres GB; Silva DC; Jasiulionis MG
    Mol Cancer; 2013 Mar; 12():22. PubMed ID: 23522389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constitutive RAC activation is not sufficient to initiate melanocyte neoplasia but accelerates malignant progression.
    Dalton LE; Kamarashev J; Barinaga-Rementeria Ramirez I; White G; Malliri A; Hurlstone A
    J Invest Dermatol; 2013 Jun; 133(6):1572-81. PubMed ID: 23337888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial nitric oxide synthase uncoupling as a key mediator of melanocyte malignant transformation associated with sustained stress conditions.
    Melo FH; Molognoni F; Morais AS; Toricelli M; Mouro MG; Higa EM; Lopes JD; Jasiulionis MG
    Free Radic Biol Med; 2011 May; 50(10):1263-73. PubMed ID: 21362470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic reprogramming as a key contributor to melanocyte malignant transformation.
    Molognoni F; Cruz AT; Meliso FM; Morais AS; Souza CF; Xander P; Bischof JM; Costa FF; Soares MB; Liang G; Jones PA; Jasiulionis MG
    Epigenetics; 2011 Apr; 6(4):450-64. PubMed ID: 21343701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MGSA/GRO-mediated melanocyte transformation involves induction of Ras expression.
    Wang D; Yang W; Du J; Devalaraja MN; Liang P; Matsumoto K; Tsubakimoto K; Endo T; Richmond A
    Oncogene; 2000 Sep; 19(40):4647-59. PubMed ID: 11030154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-Kit mutants require hypoxia-inducible factor 1alpha to transform melanocytes.
    Monsel G; Ortonne N; Bagot M; Bensussan A; Dumaz N
    Oncogene; 2010 Jan; 29(2):227-36. PubMed ID: 19802003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The AP-1 transcription factor FOSL1 causes melanocyte reprogramming and transformation.
    Maurus K; Hufnagel A; Geiger F; Graf S; Berking C; Heinemann A; Paschen A; Kneitz S; Stigloher C; Geissinger E; Otto C; Bosserhoff A; Schartl M; Meierjohann S
    Oncogene; 2017 Sep; 36(36):5110-5121. PubMed ID: 28481878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress in melanocyte senescence and melanoma transformation.
    Meierjohann S
    Eur J Cell Biol; 2014; 93(1-2):36-41. PubMed ID: 24342719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated mutant NRas(Q61K) drives aberrant melanocyte signaling, survival, and invasiveness via a Rac1-dependent mechanism.
    Li A; Ma Y; Jin M; Mason S; Mort RL; Blyth K; Larue L; Sansom OJ; Machesky LM
    J Invest Dermatol; 2012 Nov; 132(11):2610-21. PubMed ID: 22718121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction: Ras and Rac1, frequently mutated in melanomas, are activated by superoxide anion, modulate Dnmt1 level and are causally related to melanocyte malignant transformation.
    Molognoni F; de Melo FH; da Silva CT; Jasiulionis MG
    PLoS One; 2015; 10(4):e0124983. PubMed ID: 25874999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of cellular protooncogene activation and transformation-related activity of human melanocytes and metastatic melanoma.
    Husain Z; FitzGerald GB; Wick MM
    J Invest Dermatol; 1990 Nov; 95(5):571-5. PubMed ID: 2121834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melanocyte transformation requires complete loss of all pocket protein function via a mechanism that mitigates the need for MAPK pathway activation.
    Tonks ID; Mukhopadhyay P; Schroder WA; Sorolla A; Mould AW; Handoko HY; Ferguson B; Muller HK; Keith P; Hayward NK; Walker GJ; Kay GF
    Oncogene; 2017 Jun; 36(26):3789-3795. PubMed ID: 28192409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative stress-induced epigenetic changes associated with malignant transformation of human kidney epithelial cells.
    Mahalingaiah PK; Ponnusamy L; Singh KP
    Oncotarget; 2017 Feb; 8(7):11127-11143. PubMed ID: 27655674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Akt3 and mutant V600E B-Raf cooperate to promote early melanoma development.
    Cheung M; Sharma A; Madhunapantula SV; Robertson GP
    Cancer Res; 2008 May; 68(9):3429-39. PubMed ID: 18451171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of BRAF mutation and p53 inactivation during transformation of a subpopulation of primary human melanocytes.
    Yu H; McDaid R; Lee J; Possik P; Li L; Kumar SM; Elder DE; Van Belle P; Gimotty P; Guerra M; Hammond R; Nathanson KL; Dalla Palma M; Herlyn M; Xu X
    Am J Pathol; 2009 Jun; 174(6):2367-77. PubMed ID: 19389934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RGS6 suppresses Ras-induced cellular transformation by facilitating Tip60-mediated Dnmt1 degradation and promoting apoptosis.
    Huang J; Stewart A; Maity B; Hagen J; Fagan RL; Yang J; Quelle DE; Brenner C; Fisher RA
    Oncogene; 2014 Jul; 33(27):3604-11. PubMed ID: 23995786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of epidermal growth factor receptor signaling in RAS-driven melanoma.
    Bardeesy N; Kim M; Xu J; Kim RS; Shen Q; Bosenberg MW; Wong WH; Chin L
    Mol Cell Biol; 2005 May; 25(10):4176-88. PubMed ID: 15870287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue inhibitor of metalloproteinase 1 expression associated with gene demethylation confers anoikis resistance in early phases of melanocyte malignant transformation.
    Ricca TI; Liang G; Suenaga AP; Han SW; Jones PA; Jasiulionis MG
    Transl Oncol; 2009 Dec; 2(4):329-40. PubMed ID: 19956395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.